1. Home
  2. ARMP vs OPRT Comparison

ARMP vs OPRT Comparison

Compare ARMP & OPRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Armata Pharmaceuticals Inc.

ARMP

Armata Pharmaceuticals Inc.

HOLD

Current Price

$5.45

Market Cap

295.5M

Sector

Health Care

ML Signal

HOLD

Logo Oportun Financial Corporation

OPRT

Oportun Financial Corporation

HOLD

Current Price

$5.95

Market Cap

263.0M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARMP
OPRT
Founded
N/A
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
295.5M
263.0M
IPO Year
1996
2019

Fundamental Metrics

Financial Performance
Metric
ARMP
OPRT
Price
$5.45
$5.95
Analyst Decision
Strong Buy
Buy
Analyst Count
2
2
Target Price
$15.00
$7.00
AVG Volume (30 Days)
189.6K
497.6K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
127.18
EPS
N/A
0.05
Revenue
N/A
$956,685,000.00
Revenue This Year
N/A
$32.79
Revenue Next Year
N/A
$4.47
P/E Ratio
N/A
$118.00
Revenue Growth
N/A
N/A
52 Week Low
$2.14
$4.03
52 Week High
$14.98
$7.33

Technical Indicators

Market Signals
Indicator
ARMP
OPRT
Relative Strength Index (RSI) 32.23 67.94
Support Level $5.14 $5.06
Resistance Level $7.67 $6.19
Average True Range (ATR) 0.71 0.25
MACD -0.09 0.08
Stochastic Oscillator 1.57 84.51

Price Performance

Historical Comparison
ARMP
OPRT

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.

About OPRT Oportun Financial Corporation

Oportun Financial Corp is engaged in providing financial services to people who either do not have a credit score or who may have a limited credit history. The company offers Personal Loans, Auto Loans, unsecured personal loans, and secured personal loans, and provides deposit accounts, debit card services, and other transaction services to its customers. Its product offerings include small-dollar, unsecured installment loans and other products and services.

Share on Social Networks: